Libervant — United Healthcare

Initial criteria

• Diagnosis of seizure clusters or acute repetitive seizures that are distinct from the patient’s usual seizure pattern

Reauthorization criteria

• Documentation of positive clinical response to therapy

Approval duration

12 months